Published in Osteoporos Int on January 01, 2000
FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int (2008) 8.75
Assessment of fracture risk. Osteoporos Int (2004) 5.15
Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med (2010) 4.24
Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis. Osteoporos Int (2010) 1.69
Validation of a 4-item score predicting hip fracture and mortality risk among elderly women. Ann Fam Med (2007) 1.48
BMD, clinical risk factors and their combination for hip fracture prevention. Osteoporos Int (2009) 1.12
Fracture Reduction Affects Medicare Economics (FRAME): impact of increased osteoporosis diagnosis and treatment. Osteoporos Int (2005) 1.07
Incorporating adherence into health economic modelling of osteoporosis. Osteoporos Int (2008) 1.06
The Elders Risk Assessment Index, an electronic administrative database-derived frailty index, can identify risk of hip fracture in a cohort of community-dwelling adults. Mayo Clin Proc (2012) 1.00
Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries--an economic evaluation based on the fracture intervention trial. Osteoporos Int (2007) 1.00
Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study. Osteoporos Int (2004) 0.99
An economic evaluation of strontium ranelate in the treatment of osteoporosis in a Swedish setting: based on the results of the SOTI and TROPOS trials. Osteoporos Int (2006) 0.96
The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective. Osteoporos Int (2006) 0.96
A FRAX® model for the assessment of fracture probability in Belgium. Osteoporos Int (2010) 0.94
The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden. Osteoporos Int (2008) 0.89
T-plus Z-score in the assessment of relative fracture risk. Wien Med Wochenschr (2007) 0.88
Skeletal fragility definition. Clin Cases Miner Bone Metab (2011) 0.88
Hip and fragility fracture prediction by 4-item clinical risk score and mobile heel BMD: a women cohort study. BMC Musculoskelet Disord (2010) 0.85
Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women. Osteoporos Int (2004) 0.85
Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective. Osteoporos Int (2010) 0.84
Goal-directed treatment of osteoporosis in Europe. Osteoporos Int (2014) 0.84
Use of anthropometric indicators in screening for undiagnosed vertebral fractures: a cross-sectional analysis of the Fukui Osteoporosis Cohort (FOC) study. BMC Musculoskelet Disord (2008) 0.83
Economic evaluation of parathyroid hormone (PTH) in the treatment of osteoporosis in postmenopausal women. Osteoporos Int (2005) 0.82
Fracture risk prediction: importance of age, BMD and spine fracture status. Bonekey Rep (2013) 0.81
CER1 gene variations associated with bone mineral density, bone markers, and early menopause in postmenopausal women. Hum Genomics (2013) 0.80
Cost-effectiveness analysis of hip fracture prevention with vitamin D supplementation: a Markov micro-simulation model applied to the French population over 65 years old without previous hip fracture. Osteoporos Int (2014) 0.79
Logistic regression in estimates of femoral neck fracture by fall. Open Access Emerg Med (2010) 0.78
Osteoporosis in healthy South Indian males and the influence of life style factors and vitamin d status on bone mineral density. J Osteoporos (2014) 0.77
Sensitivity of osteoporosis screening guidelines for eventual hip fracture in older male veterans. Bonekey Rep (2014) 0.75
Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain. Clinicoecon Outcomes Res (2015) 0.75
A clinical decision support system for the diagnosis, fracture risks and treatment of osteoporosis. Comput Math Methods Med (2015) 0.75
Statistical methods of estimating fracture risk. Wien Med Wochenschr (2006) 0.75
A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women. Osteoporos Int (2016) 0.75
Standardised Nordic questionnaires for the analysis of musculoskeletal symptoms. Appl Ergon (1987) 14.07
Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ (1996) 11.60
FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int (2008) 8.75
World-wide projections for hip fracture. Osteoporos Int (1997) 6.83
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54
A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92
Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis. Lancet (1992) 4.75
Lifetime success and interactions of farm salmon invading a native population. Proc Biol Sci (2000) 3.53
Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK. Osteoporos Int (2008) 3.44
A prospective randomised trial of internal fixation versus arthroplasty for displaced fractures of the neck of the femur. Functional outcome for 450 patients at two years. J Bone Joint Surg Br (2002) 3.40
Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int (2001) 3.23
Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2002) 3.16
Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08
Exercise during growth and bone mineral density and fractures in old age. Lancet (2000) 3.06
Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int (2000) 2.99
An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int (2001) 2.94
The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int (2001) 2.81
A conceptual model for work-related neck and upper-limb musculoskeletal disorders. Scand J Work Environ Health (1993) 2.80
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
The components of excess mortality after hip fracture. Bone (2003) 2.63
Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res (2000) 2.55
Validity of self-report of fractures: results from a prospective study in men and women across Europe. EPOS Study Group. European Prospective Osteoporosis Study Group. Osteoporos Int (2000) 2.52
Photorefractoriness in birds and comparison with mammals. Physiol Rev (1988) 2.46
The costs of asthma. Eur Respir J (1996) 2.44
Interpretation and use of FRAX in clinical practice. Osteoporos Int (2011) 2.43
Projecting the need for hip replacement over the next three decades: influence of changing demography and threshold for surgery. Ann Rheum Dis (1999) 2.36
SHBG gene promoter polymorphisms in men are associated with serum sex hormone-binding globulin, androgen and androgen metabolite levels, and hip bone mineral density. J Clin Endocrinol Metab (2006) 2.25
Pitfalls in the external validation of FRAX. Osteoporos Int (2011) 2.21
Regional distribution of ventilation and perfusion as a function of body position. J Appl Physiol (1966) 2.20
Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int (1999) 2.20
Routine histological examination of the mastectomy scar at the time of breast reconstruction: important oncological surveillance? Br J Plast Surg (2004) 2.14
A family history of fracture and fracture risk: a meta-analysis. Bone (2004) 2.13
Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int (2004) 2.11
Transposition of the Drosophila element mariner into the chicken germ line. Nat Biotechnol (1998) 2.09
Development and use of FRAX in osteoporosis. Osteoporos Int (2010) 2.04
Conservative treatment of acute low-back pain. A prospective randomized trial: McKenzie method of treatment versus patient education in "mini back school". Spine (Phila Pa 1976) (1990) 2.01
Adrenocortical function in acquired immunodeficiency syndrome. J Clin Endocrinol Metab (1987) 1.99
Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone (2000) 1.89
Long-term follow-up of patients with untreated scoliosis. A study of mortality, causes of death, and symptoms. Spine (Phila Pa 1976) (1992) 1.88
Epithelial-myoepithelial carcinomas of the bronchus. Am J Surg Pathol (2001) 1.85
Variation in the expression of blood group antigen A in clonal cultures of rabbit cells. Exp Cell Res (1966) 1.85
Does routine intraoperative cholangiography prevent bile duct transection? Surg Endosc (2005) 1.85
The apparent incidence of hip fracture in Europe: a study of national register sources. Osteoporos Int (1992) 1.81
Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX). Osteoporos Int (2008) 1.77
Mortality associated with vertebral deformity in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (1998) 1.76
Are the findings in the Swedish National Total Hip Arthroplasty Register valid? A comparison between the Swedish National Total Hip Arthroplasty Register, the National Discharge Register, and the National Death Register. J Arthroplasty (2000) 1.75
A high incidence of vertebral fracture in women with breast cancer. Br J Cancer (1999) 1.74
The risk and burden of vertebral fractures in Sweden. Osteoporos Int (2003) 1.74
Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study. Osteoporos Int (2003) 1.74
Acute and long-term increase in fracture risk after hospitalization for stroke. Stroke (2001) 1.73
A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int (2002) 1.70
Health-related quality of life and radiographic vertebral fracture. Osteoporos Int (2003) 1.70
Chernobyl radioactivity persists in fish. Nature (1999) 1.69
The effect of caries-preventive measures in mothers on dental caries and the oral presence of the bacteria Streptococcus mutans and lactobacilli in their children. Arch Oral Biol (1984) 1.67
A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas (1995) 1.67
Surgical versus non-surgical treatment of ligamentous injuries following dislocation of the elbow joint. A prospective randomized study. J Bone Joint Surg Am (1987) 1.63
Factors affecting the expression of blood group antigen A in cultured cells. Exp Cell Res (1967) 1.61
Bone mineral density predicts non-spine fractures in very elderly women. Study of Osteoporotic Fractures Research Group. Osteoporos Int (1994) 1.60
Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study. Osteoporos Int (1999) 1.59
Frailty and sarcopenia: definitions and outcome parameters. Osteoporos Int (2012) 1.58
Incidence of limb fracture across Europe: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2002) 1.56
DNA-binding activity and subunit interaction of the mariner transposase. Nucleic Acids Res (2001) 1.55
Cancer risk after hip replacement with metal implants: a population-based cohort study in Sweden. J Natl Cancer Inst (1995) 1.53
Consequences of a hip fracture: a prospective study over 1 year. Osteoporos Int (1993) 1.53
Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment. Ann Rheum Dis (2000) 1.53
Enzyme replacement therapy for Gaucher disease. Blood (1991) 1.48
Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group. BMJ (1998) 1.48
Incidence of hip fractures in Malmö, Sweden, 1992-1995. A trend-break. Acta Orthop Scand (1999) 1.48
Increasing age-adjusted risk of fragility fractures: a sign of increasing osteoporosis in successive generations? Calcif Tissue Int (1989) 1.48
The earlier the colonization by mutans streptococci, the higher the caries prevalence at 4 years of age. Oral Microbiol Immunol (1988) 1.47
What is the role of the research ethics committee? Paternalism, inducements, and harm in research ethics. J Med Ethics (2005) 1.47
The variable incidence of hip fracture in southern Europe: the MEDOS Study. Osteoporos Int (1994) 1.46
The excess mortality due to periprosthetic femur fracture. A study from the Swedish national hip arthroplasty register. Bone (2007) 1.46